Observations placeholder
Hallucinations and hypoglycemia from ciprofloxacin
Identifier
013004
Type of Spiritual Experience
Background
1. Ciprofloxacin (INN) is an antibiotic used for a number of bacterial infections. It is a second-generation fluoroquinolone. It is used for bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections, including Gram-negative (Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Proteus mirabilis, and Pseudomonas aeruginosa), and Gram-positive (methicillin-sensitive, but not methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, Enterococcus faecalis, and Streptococcus pyogenes) bacterial pathogens.Ciprofloxacin (INN) is an antibiotic used for a number of bacterial infections. It is a second-generation fluoroquinolone. It is used for bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections, including Gram-negative (Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Proteus mirabilis, and Pseudomonas aeruginosa), and Gram-positive (methicillin-sensitive, but not methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, Enterococcus faecalis, and Streptococcus pyogenes) bacterial pathogens.
2. It should be noted that this study only looked at the short term consequences of use, the long term consequences of use on, for example, intestinal flora was not considered.
3. The terms thrombocytopenia and thrombopenia refer to a relative decrease of platelets in blood.
4. The other symptoms were partly caused by hypoglycemia
A description of the experience
Pharmacotherapy. 1993 Sep-Oct;13(5):461-4.
A follow-up safety study of ciprofloxacin users.
Jick SS1, Jick H, Dean AD. 1Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA 02173.
We followed 37,233 outpatients for 45 days after receiving a prescription for ciprofloxacin to identify any newly diagnosed, important illnesses that might have been caused by the drug.
For 29 users the role of ciprofloxacin in the etiology of the illness could not be confidently ruled out (7.79/10,000 persons; 95% CI 5.42-11.18).
In only seven was a causal relation to ciprofloxacin considered likely: three skin reactions and one case each of thrombocytopenia, "headache, nausea, and shakes," hallucinations, and palpitations.
No fatal illnesses occurred, and all patients recovered after discontinuing the drug. In addition, few cases of photosensitivity were associated with the agent.
PMID: 8247912
The source of the experience
PubMedConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
AntibioticsBlood circulatory system disease
Blood thinners
Haemophilus influenzae infection
Hypoglycemia
Skin diseases